Ad
ALXN - Alexion Pharmaceuticals Stock Trading
About | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
Not available
Quote | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
| Last: | $182.50 |
|---|---|
| Change Percent: | 1.7% |
| Open: | $181.04 |
| Close: | $182.50 |
| High: | $182.67 |
| Low: | $180.13 |
| Volume: | 86,925,205 |
| Last Trade Date Time: | 07/20/2021 04:42:03 am |
News | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
-
2023-12-03 12:00:30 ET More on SPDR S&P Biotech ETF Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Biopharma Bounce-Back: From Policy Pains To Profitable Plains Biotechs rally with gene editing stocks among nota...
-
2023-10-27 11:56:53 ET Summary Xencor is expected to release data from a phase 2 study in early 2024 targeting patients with mCRPC and gynecological cancers, which could generate shareholder value. The global metastatic castration-resistant prostate cancer treatment market is expe...
Message Board Posts | Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)
| Subject | By | Source | When |
|---|---|---|---|
| znewcar1: ALXN 29% v22,3M c156.31 f218M Buy out | znewcar1 | investorshangout | 12/14/2020 10:15:38 PM |
| JUST IN: $ALXN 2 Top Pharma Stocks to | whytestocks | investorshub | 10/24/2020 12:00:28 PM |
| JUST IN: $ALXN Labor Day Special: 3 Deep-Discount | whytestocks | investorshub | 09/07/2020 12:00:23 PM |
| ALXN SEC Admin. Proceeding: Cease and Desist Order: | Renee | investorshub | 07/02/2020 1:40:22 PM |
| This Pharma is in due diligence with another | Inthe203 | investorshub | 01/25/2020 10:22:03 PM |
News, Short Squeeze, Breakout and More Instantly...
Alexion Pharmaceuticals Inc. Company Name:
ALXN Stock Symbol:
NASDAQ Market:
Alexion Pharmaceuticals Inc. Website:
Ad
-
AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...
-
This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...